ID   KKCC2_HUMAN             Reviewed;         588 AA.
AC   Q96RR4; A8K7Q7; O94883; Q8IUG2; Q8IUG3; Q8N3I4; Q8WY03; Q8WY04;
AC   Q8WY05; Q8WY06; Q96RP1; Q96RP2; Q96RR3; Q9BWE9; Q9UER3; Q9UES2;
AC   Q9Y5N2;
DT   07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 2.
DT   10-MAY-2017, entry version 148.
DE   RecName: Full=Calcium/calmodulin-dependent protein kinase kinase 2;
DE            Short=CaM-KK 2;
DE            Short=CaM-kinase kinase 2;
DE            Short=CaMKK 2;
DE            EC=2.7.11.17;
DE   AltName: Full=Calcium/calmodulin-dependent protein kinase kinase beta;
DE            Short=CaM-KK beta;
DE            Short=CaM-kinase kinase beta;
DE            Short=CaMKK beta;
GN   Name=CAMKK2; Synonyms=CAMKKB, KIAA0787;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1; 2; 3; 4; 5 AND
RP   6), FUNCTION, AND VARIANT SER-85.
RX   PubMed=11395482; DOI=10.1074/jbc.M011720200;
RA   Hsu L.-S., Chen G.-D., Lee L.-S., Chi C.-W., Cheng J.-F., Chen J.-Y.;
RT   "Human Ca2+/calmodulin-dependent protein kinase kinase beta gene
RT   encodes multiple isoforms that display distinct kinase activity.";
RL   J. Biol. Chem. 276:31113-31123(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain cortex;
RX   PubMed=9822657; DOI=10.1074/jbc.273.48.31880;
RA   Anderson K.A., Means R.L., Huang Q.-H., Kemp B.E., Goldstein E.G.,
RA   Selbert M.A., Edelman A.M., Fremeau R.T., Means A.R.;
RT   "Components of a calmodulin-dependent protein kinase cascade.
RT   Molecular cloning, functional characterization and cellular
RT   localization of Ca2+/calmodulin-dependent protein kinase kinase
RT   beta.";
RL   J. Biol. Chem. 273:31880-31889(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND FUNCTION IN
RP   PHOSPHORYLATION OF CAMK1D.
RX   PubMed=12935886; DOI=10.1016/S0014-5793(03)00817-2;
RA   Ishikawa Y., Tokumitsu H., Inuzuka H., Murata-Hori M., Hosoya H.,
RA   Kobayashi R.;
RT   "Identification and characterization of novel components of a
RT   Ca2+/calmodulin-dependent protein kinase cascade in HeLa cells.";
RL   FEBS Lett. 550:57-63(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7), AND VARIANT
RP   SER-85.
RC   TISSUE=Brain;
RX   PubMed=9872452; DOI=10.1093/dnares/5.5.277;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Miyajima N., Tanaka A.,
RA   Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XI.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 5:277-286(1998).
RN   [5]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Stomach;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 233-588 (ISOFORM 5), AND VARIANT
RP   SER-85.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 117-588 (ISOFORM 2), FUNCTION IN
RP   PHOSPHORYLATION OF CAMK1, AND TISSUE SPECIFICITY.
RX   PubMed=9662074; DOI=10.1007/BF02258368;
RA   Hsu L.-S., Tsou A.-P., Chi C.-W., Lee C.-H., Chen J.-Y.;
RT   "Cloning, expression and chromosomal localization of human
RT   Ca2+/calmodulin-dependent protein kinase kinase.";
RL   J. Biomed. Sci. 5:141-149(1998).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 254-588 (ISOFORM 7).
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 338-533 (ISOFORM 2).
RA   Barrow I.K.-P., Boguski M.S., Touchman J.W., Spencer F.;
RT   "Full-insert sequence of mapped XREF EST.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-495, PHOSPHORYLATION
RP   [LARGE SCALE ANALYSIS] AT SER-522 (ISOFORM 3), PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-479 (ISOFORM 5), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   FUNCTION, SUBCELLULAR LOCATION, AUTOPHOSPHORYLATION, PHOSPHORYLATION
RP   BY PKA, AND INDUCTION OF ISOFORM 1.
RX   PubMed=21957496; DOI=10.4161/rna.8.6.16691;
RA   Cao W., Sohail M., Liu G., Koumbadinga G.A., Lobo V.G., Xie J.;
RT   "Differential effects of PKA-controlled CaMKK2 variants on neuronal
RT   differentiation.";
RL   RNA Biol. 8:1061-1072(2011).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114; SER-129; SER-495
RP   AND SER-511, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-495, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASN-10; SER-85; TYR-123; LEU-127;
RP   THR-182 AND HIS-492.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Calcium/calmodulin-dependent protein kinase belonging to
CC       a proposed calcium-triggered signaling cascade involved in a
CC       number of cellular processes. Isoform 1, isoform 2 and isoform 3
CC       phosphorylate CAMK1 and CAMK4. Isoform 3 phosphorylates CAMK1D.
CC       Isoform 4, isoform 5 and isoform 6 lacking part of the calmodulin-
CC       binding domain are inactive. Efficiently phosphorylates 5'-AMP-
CC       activated protein kinase (AMPK) trimer, including that consisting
CC       of PRKAA1, PRKAB1 and PRKAG1. This phosphorylation is stimulated
CC       in response to Ca(2+) signals (By similarity). Seems to be
CC       involved in hippocampal activation of CREB1 (By similarity). May
CC       play a role in neurite growth. Isoform 3 may promote neurite
CC       elongation, while isoform 1 may promoter neurite branching.
CC       {ECO:0000250, ECO:0000269|PubMed:11395482,
CC       ECO:0000269|PubMed:12935886, ECO:0000269|PubMed:21957496,
CC       ECO:0000269|PubMed:9662074}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Activated by Ca(2+)/calmodulin. Binding of
CC       calmodulin may relieve intrasteric autoinhibition.
CC       Autophosphorylation does not alter activity or regulation by
CC       Ca(2+)/calmodulin. In part, activity is independent on
CC       Ca(2+)/calmodulin (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with calmodulin. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm
CC       {ECO:0000269|PubMed:21957496}. Cell projection
CC       {ECO:0000269|PubMed:21957496}. Note=Predominantly nuclear in
CC       unstimulated cells (By similarity). Found in the cytoplasm and
CC       neurites after forskolin induction. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1; Synonyms=Beta1, CAMKK2+E16;
CC         IsoId=Q96RR4-1; Sequence=Displayed;
CC         Note=Major isoform.;
CC       Name=2; Synonyms=Beta2;
CC         IsoId=Q96RR4-2; Sequence=VSP_012146, VSP_012147, VSP_012149;
CC         Note=Major isoform.;
CC       Name=3; Synonyms=Beta1delta16, CAMKK2-E16;
CC         IsoId=Q96RR4-3; Sequence=VSP_012143, VSP_012144, VSP_012145,
CC                                  VSP_012149;
CC         Note=Contains a phosphoserine at position 522.
CC         {ECO:0000244|PubMed:18691976};
CC       Name=4; Synonyms=Beta1delta14;
CC         IsoId=Q96RR4-4; Sequence=VSP_012142;
CC       Name=5; Synonyms=Beta1delta14/16, beta-3x;
CC         IsoId=Q96RR4-5; Sequence=VSP_012142, VSP_012143, VSP_012144,
CC                                  VSP_012145, VSP_012149;
CC         Note=Inactive. Does not activate CAMK1 and CAMK4. Contains a
CC         phosphoserine at position 479. {ECO:0000244|PubMed:18691976};
CC       Name=6; Synonyms=Beta2delta14;
CC         IsoId=Q96RR4-6; Sequence=VSP_012142, VSP_012146, VSP_012147,
CC                                  VSP_012149;
CC         Note=Inactive. Does not activate CAMK1 and CAMK4.;
CC       Name=7;
CC         IsoId=Q96RR4-7; Sequence=VSP_012148, VSP_012149;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed with higher levels in
CC       the brain. Intermediate levels are detected in spleen, prostate,
CC       thyroid and leukocytes. The lowest level is in lung.
CC       {ECO:0000269|PubMed:9662074}.
CC   -!- INDUCTION: Isoform 1 is up-regulated by PKA pathway.
CC       {ECO:0000269|PubMed:21957496}.
CC   -!- DOMAIN: The autoinhibitory domain overlaps with the calmodulin
CC       binding region and may be involved in intrasteric autoinhibition.
CC   -!- DOMAIN: The RP domain (arginine/proline-rich) is involved in the
CC       recognition of CAMKI and CAMK4 as substrates. {ECO:0000250}.
CC   -!- PTM: Autophosphorylated and phosphorylated by PKA. Each isoform
CC       may show a different pattern of phosphorylation.
CC       {ECO:0000269|PubMed:21957496}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC72943.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAA34507.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=CAD38990.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB081337; BAC19841.1; -; mRNA.
DR   EMBL; AF287630; AAK64600.1; -; mRNA.
DR   EMBL; AF287631; AAK64601.1; -; mRNA.
DR   EMBL; AF321385; AAL37215.1; -; mRNA.
DR   EMBL; AF321386; AAL37216.1; -; mRNA.
DR   EMBL; AF321387; AAL37217.1; -; mRNA.
DR   EMBL; AF321388; AAL37218.1; -; mRNA.
DR   EMBL; AF321401; AAK91830.1; -; Genomic_DNA.
DR   EMBL; AF321390; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321391; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321392; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321393; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321394; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321395; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321396; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321397; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321398; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321399; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321400; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321575; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321576; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321577; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321578; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321402; AAK91829.1; -; Genomic_DNA.
DR   EMBL; AF321390; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321391; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321392; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321393; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321394; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321395; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321396; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321397; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321398; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321399; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321400; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321575; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321576; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321577; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321578; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF140507; AAD31507.1; -; mRNA.
DR   EMBL; AB081336; BAC19840.1; -; mRNA.
DR   EMBL; AB018330; BAA34507.2; ALT_INIT; mRNA.
DR   EMBL; AK292072; BAF84761.1; -; mRNA.
DR   EMBL; AC069209; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000318; AAH00318.2; -; mRNA.
DR   EMBL; BC026060; AAH26060.1; -; mRNA.
DR   EMBL; AF101264; AAD04566.1; -; mRNA.
DR   EMBL; AL834322; CAD38990.1; ALT_SEQ; mRNA.
DR   EMBL; AF091074; AAC72943.1; ALT_INIT; mRNA.
DR   CCDS; CCDS44999.1; -. [Q96RR4-2]
DR   CCDS; CCDS53837.1; -. [Q96RR4-6]
DR   CCDS; CCDS58283.1; -. [Q96RR4-7]
DR   CCDS; CCDS9216.1; -. [Q96RR4-1]
DR   CCDS; CCDS9217.1; -. [Q96RR4-4]
DR   CCDS; CCDS9218.1; -. [Q96RR4-3]
DR   CCDS; CCDS9219.1; -. [Q96RR4-5]
DR   PIR; JE0191; JE0191.
DR   RefSeq; NP_001257414.1; NM_001270485.1. [Q96RR4-1]
DR   RefSeq; NP_001257415.1; NM_001270486.1. [Q96RR4-7]
DR   RefSeq; NP_006540.3; NM_006549.3. [Q96RR4-1]
DR   RefSeq; NP_705719.2; NM_153499.2. [Q96RR4-3]
DR   RefSeq; NP_705720.1; NM_153500.1. [Q96RR4-5]
DR   RefSeq; NP_757363.1; NM_172214.2. [Q96RR4-2]
DR   RefSeq; NP_757364.1; NM_172215.2. [Q96RR4-6]
DR   RefSeq; NP_757365.1; NM_172216.1. [Q96RR4-4]
DR   RefSeq; NP_757380.1; NM_172226.2. [Q96RR4-3]
DR   RefSeq; XP_005253880.1; XM_005253823.1. [Q96RR4-2]
DR   RefSeq; XP_005253881.1; XM_005253824.3. [Q96RR4-5]
DR   RefSeq; XP_011536065.1; XM_011537763.1. [Q96RR4-7]
DR   RefSeq; XP_016874187.1; XM_017018698.1. [Q96RR4-1]
DR   RefSeq; XP_016874190.1; XM_017018701.1. [Q96RR4-7]
DR   RefSeq; XP_016874191.1; XM_017018702.1. [Q96RR4-7]
DR   RefSeq; XP_016874193.1; XM_017018704.1. [Q96RR4-2]
DR   UniGene; Hs.297343; -.
DR   PDB; 2ZV2; X-ray; 2.40 A; A=158-448.
DR   PDB; 5UY6; X-ray; 1.70 A; A=161-449.
DR   PDBsum; 2ZV2; -.
DR   PDBsum; 5UY6; -.
DR   ProteinModelPortal; Q96RR4; -.
DR   SMR; Q96RR4; -.
DR   BioGrid; 115889; 29.
DR   IntAct; Q96RR4; 19.
DR   STRING; 9606.ENSP00000312741; -.
DR   BindingDB; Q96RR4; -.
DR   ChEMBL; CHEMBL5284; -.
DR   GuidetoPHARMACOLOGY; 1957; -.
DR   iPTMnet; Q96RR4; -.
DR   PhosphoSitePlus; Q96RR4; -.
DR   BioMuta; CAMKK2; -.
DR   DMDM; 317373374; -.
DR   EPD; Q96RR4; -.
DR   MaxQB; Q96RR4; -.
DR   PaxDb; Q96RR4; -.
DR   PeptideAtlas; Q96RR4; -.
DR   PRIDE; Q96RR4; -.
DR   DNASU; 10645; -.
DR   Ensembl; ENST00000324774; ENSP00000312741; ENSG00000110931. [Q96RR4-1]
DR   Ensembl; ENST00000337174; ENSP00000336634; ENSG00000110931. [Q96RR4-3]
DR   Ensembl; ENST00000347034; ENSP00000321230; ENSG00000110931. [Q96RR4-4]
DR   Ensembl; ENST00000392473; ENSP00000376265; ENSG00000110931. [Q96RR4-2]
DR   Ensembl; ENST00000392474; ENSP00000376266; ENSG00000110931. [Q96RR4-7]
DR   Ensembl; ENST00000402834; ENSP00000384591; ENSG00000110931. [Q96RR4-1]
DR   Ensembl; ENST00000404169; ENSP00000384600; ENSG00000110931. [Q96RR4-1]
DR   Ensembl; ENST00000412367; ENSP00000388368; ENSG00000110931. [Q96RR4-3]
DR   Ensembl; ENST00000446440; ENSP00000388273; ENSG00000110931. [Q96RR4-6]
DR   Ensembl; ENST00000538733; ENSP00000445944; ENSG00000110931. [Q96RR4-5]
DR   GeneID; 10645; -.
DR   KEGG; hsa:10645; -.
DR   UCSC; uc001tzt.4; human. [Q96RR4-1]
DR   CTD; 10645; -.
DR   DisGeNET; 10645; -.
DR   GeneCards; CAMKK2; -.
DR   H-InvDB; HIX0011079; -.
DR   H-InvDB; HIX0171630; -.
DR   H-InvDB; HIX0171665; -.
DR   HGNC; HGNC:1470; CAMKK2.
DR   HPA; HPA017389; -.
DR   MIM; 615002; gene.
DR   neXtProt; NX_Q96RR4; -.
DR   OpenTargets; ENSG00000110931; -.
DR   PharmGKB; PA26052; -.
DR   eggNOG; KOG0585; Eukaryota.
DR   eggNOG; ENOG410YHHF; LUCA.
DR   GeneTree; ENSGT00530000063214; -.
DR   HOVERGEN; HBG052262; -.
DR   InParanoid; Q96RR4; -.
DR   KO; K07359; -.
DR   OMA; MNGRCIC; -.
DR   OrthoDB; EOG091G01DB; -.
DR   PhylomeDB; Q96RR4; -.
DR   TreeFam; TF313013; -.
DR   BRENDA; 2.7.11.17; 2681.
DR   SignaLink; Q96RR4; -.
DR   SIGNOR; Q96RR4; -.
DR   ChiTaRS; CAMKK2; human.
DR   EvolutionaryTrace; Q96RR4; -.
DR   GeneWiki; CAMKK2; -.
DR   GenomeRNAi; 10645; -.
DR   PRO; PR:Q96RR4; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000110931; -.
DR   CleanEx; HS_CAMKK2; -.
DR   ExpressionAtlas; Q96RR4; baseline and differential.
DR   Genevisible; Q96RR4; HS.
DR   GO; GO:0042995; C:cell projection; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005622; C:intracellular; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; TAS:UniProtKB.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; IBA:GO_Central.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; TAS:UniProtKB.
DR   GO; GO:0019722; P:calcium-mediated signaling; TAS:UniProtKB.
DR   GO; GO:0061762; P:CAMKK-AMPK signaling cascade; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0034614; P:cellular response to reactive oxygen species; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0000165; P:MAPK cascade; TAS:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IBA:GO_Central.
DR   GO; GO:1903599; P:positive regulation of mitophagy; IC:ParkinsonsUK-UCL.
DR   GO; GO:0045860; P:positive regulation of protein kinase activity; IBA:GO_Central.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; TAS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0045859; P:regulation of protein kinase activity; TAS:UniProtKB.
DR   InterPro; IPR020636; Ca/CaM-dep_Ca-dep_prot_Kinase.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24347; PTHR24347; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Calmodulin-binding; Cell projection; Complete proteome; Cytoplasm;
KW   Kinase; Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    588       Calcium/calmodulin-dependent protein
FT                                kinase kinase 2.
FT                                /FTId=PRO_0000086144.
FT   DOMAIN      165    446       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     171    179       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION      204    226       RP domain.
FT   REGION      472    477       Autoinhibitory domain. {ECO:0000250}.
FT   REGION      475    500       Calmodulin-binding. {ECO:0000250}.
FT   ACT_SITE    312    312       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     194    194       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     100    100       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8C078}.
FT   MOD_RES     114    114       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     129    129       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     133    133       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8C078}.
FT   MOD_RES     137    137       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8C078}.
FT   MOD_RES     495    495       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     511    511       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     572    572       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8C078}.
FT   VAR_SEQ     442    484       Missing (in isoform 4, isoform 5 and
FT                                isoform 6). {ECO:0000303|PubMed:11395482,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_012142.
FT   VAR_SEQ     520    532       KPTRECESLSELK -> QGSEDNLQGTDPP (in
FT                                isoform 3 and isoform 5).
FT                                {ECO:0000303|PubMed:11395482,
FT                                ECO:0000303|PubMed:12935886,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_012143.
FT   VAR_SEQ     533    554       EARQRRQPPGHRPAPRGGGGSA -> GTKKKKGLDSMTSTV
FT                                AAGWLDRRV (in isoform 7).
FT                                {ECO:0000303|PubMed:17974005,
FT                                ECO:0000303|PubMed:9872452}.
FT                                /FTId=VSP_012148.
FT   VAR_SEQ     533    541       EARQRRQPP -> PVGEEEVLL (in isoform 3 and
FT                                isoform 5). {ECO:0000303|PubMed:11395482,
FT                                ECO:0000303|PubMed:12935886,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_012144.
FT   VAR_SEQ     533    533       E -> T (in isoform 2 and isoform 6).
FT                                {ECO:0000303|PubMed:11395482,
FT                                ECO:0000303|PubMed:9662074,
FT                                ECO:0000303|Ref.11}.
FT                                /FTId=VSP_012146.
FT   VAR_SEQ     534    554       Missing (in isoform 2 and isoform 6).
FT                                {ECO:0000303|PubMed:11395482,
FT                                ECO:0000303|PubMed:9662074,
FT                                ECO:0000303|Ref.11}.
FT                                /FTId=VSP_012147.
FT   VAR_SEQ     542    554       Missing (in isoform 3 and isoform 5).
FT                                {ECO:0000303|PubMed:11395482,
FT                                ECO:0000303|PubMed:12935886,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_012145.
FT   VAR_SEQ     555    588       Missing (in isoform 2, isoform 3, isoform
FT                                5, isoform 6 and isoform 7).
FT                                {ECO:0000303|PubMed:11395482,
FT                                ECO:0000303|PubMed:12935886,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005,
FT                                ECO:0000303|PubMed:9662074,
FT                                ECO:0000303|PubMed:9872452,
FT                                ECO:0000303|Ref.11}.
FT                                /FTId=VSP_012149.
FT   VARIANT      10     10       S -> N (in dbSNP:rs28360477).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_032788.
FT   VARIANT      85     85       T -> S (in dbSNP:rs3817190).
FT                                {ECO:0000269|PubMed:11395482,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|PubMed:9872452}.
FT                                /FTId=VAR_020532.
FT   VARIANT     123    123       C -> Y (in dbSNP:rs35403710).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040610.
FT   VARIANT     127    127       P -> L (in a lung neuroendocrine
FT                                carcinoma sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040611.
FT   VARIANT     182    182       A -> T (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040612.
FT   VARIANT     363    363       R -> C (in dbSNP:rs1132780).
FT                                /FTId=VAR_020533.
FT   VARIANT     492    492       R -> H (in dbSNP:rs34129994).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040613.
FT   CONFLICT    206    206       G -> A (in Ref. 2; AAD31507).
FT                                {ECO:0000305}.
FT   CONFLICT    331    331       F -> I (in Ref. 6; BAF84761).
FT                                {ECO:0000305}.
FT   CONFLICT    347    347       T -> Y (in Ref. 2; AAD31507).
FT                                {ECO:0000305}.
FT   CONFLICT    371    371       L -> K (in Ref. 2; AAD31507).
FT                                {ECO:0000305}.
FT   CONFLICT    554    554       A -> H (in Ref. 1; AAK91829).
FT                                {ECO:0000305}.
FT   CONFLICT    557    557       R -> N (in Ref. 1; AAK91829).
FT                                {ECO:0000305}.
FT   STRAND      165    172       {ECO:0000244|PDB:2ZV2}.
FT   STRAND      178    184       {ECO:0000244|PDB:2ZV2}.
FT   TURN        185    188       {ECO:0000244|PDB:2ZV2}.
FT   STRAND      189    197       {ECO:0000244|PDB:2ZV2}.
FT   HELIX       232    241       {ECO:0000244|PDB:2ZV2}.
FT   STRAND      251    256       {ECO:0000244|PDB:2ZV2}.
FT   STRAND      258    268       {ECO:0000244|PDB:2ZV2}.
FT   HELIX       286    305       {ECO:0000244|PDB:2ZV2}.
FT   HELIX       315    317       {ECO:0000244|PDB:2ZV2}.
FT   STRAND      318    320       {ECO:0000244|PDB:2ZV2}.
FT   STRAND      326    328       {ECO:0000244|PDB:2ZV2}.
FT   STRAND      338    341       {ECO:0000244|PDB:2ZV2}.
FT   HELIX       351    353       {ECO:0000244|PDB:2ZV2}.
FT   HELIX       356    358       {ECO:0000244|PDB:2ZV2}.
FT   STRAND      366    368       {ECO:0000244|PDB:2ZV2}.
FT   HELIX       369    385       {ECO:0000244|PDB:2ZV2}.
FT   HELIX       395    404       {ECO:0000244|PDB:2ZV2}.
FT   STRAND      411    413       {ECO:0000244|PDB:2ZV2}.
FT   HELIX       417    426       {ECO:0000244|PDB:2ZV2}.
FT   TURN        431    433       {ECO:0000244|PDB:2ZV2}.
FT   HELIX       437    440       {ECO:0000244|PDB:2ZV2}.
FT   HELIX       444    447       {ECO:0000244|PDB:2ZV2}.
SQ   SEQUENCE   588 AA;  64746 MW;  04E3583561341167 CRC64;
     MSSCVSSQPS SNRAAPQDEL GGRGSSSSES QKPCEALRGL SSLSIHLGME SFIVVTECEP
     GCAVDLGLAR DRPLEADGQE VPLDTSGSQA RPHLSGRKLS LQERSQGGLA AGGSLDMNGR
     CICPSLPYSP VSSPQSSPRL PRRPTVESHH VSITGMQDCV QLNQYTLKDE IGKGSYGVVK
     LAYNENDNTY YAMKVLSKKK LIRQAGFPRR PPPRGTRPAP GGCIQPRGPI EQVYQEIAIL
     KKLDHPNVVK LVEVLDDPNE DHLYMVFELV NQGPVMEVPT LKPLSEDQAR FYFQDLIKGI
     EYLHYQKIIH RDIKPSNLLV GEDGHIKIAD FGVSNEFKGS DALLSNTVGT PAFMAPESLS
     ETRKIFSGKA LDVWAMGVTL YCFVFGQCPF MDERIMCLHS KIKSQALEFP DQPDIAEDLK
     DLITRMLDKN PESRIVVPEI KLHPWVTRHG AEPLPSEDEN CTLVEVTEEE VENSVKHIPS
     LATVILVKTM IRKRSFGNPF EGSRREERSL SAPGNLLTKK PTRECESLSE LKEARQRRQP
     PGHRPAPRGG GGSALVRGSP CVESCWAPAP GSPARMHPLR PEEAMEPE
//
